In Depth Letters to the Editor By Pharmafield July 1, 2007 FacebookTwitterLinkedin Got something to say? Email the editor at chris.ross@healthpublishing.co.uk. - Advertisement - Previous articleCompany culture puts Recordati on the A-List of employersNext articleLife after redundancy: turning adversity into opportunity Pharmafield MORE FROM AUTHOR CareersNumab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer NewsNHS study finds that AI skin cancer tool cuts biopsy rates NewsDaiichi Sankyo and Turbine expand ADC discovery collaboration - Advertisement - LATEST POSTS Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer NHS study finds that AI skin cancer tool cuts biopsy rates Daiichi Sankyo and Turbine expand ADC discovery collaboration Trixeo approved in the EU for the maintenance treatment of asthma NICE recommends Enhertu for people with HER2-low advanced breast cancer